10.1182/blood-2013-02-483073 - Bortezomib induction, reduced-intensi...

This document has been corrected

Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results

10.1182/blood-2013-02-483073

Published Online: 2013-08-22

Journal: Blood•Publisher: American Society of Hematology

Authors: Anna Marina Liberati•Antonio Palumbo•Claudia Crippa•Federica Cavallo•Francesca Gay•Francesca Patriarca•Giuseppe Pietrantuono•Maria Teresa Petrucci•Mario Boccadoro•Massimo Offidani•Nicola Giuliani•Norbert Pescosta•Paola Omedé•Paolo Corradini•Roberto Passera•Samantha Ferrari•Sara Pezzatti•Stefania Oliva•Tommasina Guglielmelli•Valeria Magarotto•Vittorio Montefusco

This document has been corrected

Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results

10.1182/blood-2013-02-483073

Published Online: 2013-08-22

Journal: Blood

NOW

2014-06-12•Erratum

Gay F, Magarotto V, Crippa C, et al. Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results. Blood. 2013;122(8):1376-1383.

10.1182/blood-2014-04-572073

* information provided by CrossRef

2014-06-12•Erratum

10.1182/blood-2014-04-572073

* information provided by CrossRef

2013-08-22•Published

2014-06-12•Erratum

Gay F, Magarotto V, Crippa C, et al. Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results. Blood. 2013;122(8):1376-1383.

10.1182/blood-2014-04-572073

* information provided by CrossRef

This document has been corrected

Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results

10.1182/blood-2013-02-483073

Published Online: 2013-08-22

Journal: Blood•Publisher: American Society of Hematology